Financials
Financial year 2025
PHARMACIE ANS SENTERRE from Ans, company number BE0473720185, closed financial year 2025 with a result of € 22,090 after tax. For that financial year PHARMACIE ANS SENTERRE recorded a gross margin of € 25,091 and equity of € 42,430. Compared with financial year 2024, the result moved from € 5,509 to € 22,090. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 42,430
▲ 109% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 22,090
▲ € 16,582 vs 2024
Profit after tax over the fiscal year.
€ 12,800
▲ 24% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -20,070.
People and assets in 2025
€ 508
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 16,763
▼ 5% vs 2024
Loans from banks and other lenders, long and short.
€ 72,596
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 513
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 151 | € -2,211 | € 9,997 | € 25,091 | ▲ 151% |
| Profit after taxes | € -2,104 | € -4,137 | € 5,509 | € 22,090 | ▲ € 16,582 |
| Equity | € 18,968 | € 14,831 | € 20,340 | € 42,430 | ▲ 109% |
| Total debts | € 109,355 | € 77,459 | € 95,763 | € 90,355 | ▼ 6% |
| Cash | € 14,569 | € 5,455 | € 10,333 | € 12,800 | ▲ 24% |
| Retained profit | € -43,532 | € -47,669 | € -42,160 | € -20,070 | ▲ € 22,090 |
| Bank debt | € 0 | € 0 | € 17,683 | € 16,763 | ▼ 5% |
| Balance sheet total | € 128,323 | € 92,290 | € 116,102 | € 132,785 | ▲ 14% |
Key figures of PHARMACIE ANS SENTERRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE ANS SENTERRE?
What happened at PHARMACIE ANS SENTERRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- ATTE GESTION SRL stepped down as director. NBB
- Emmanuel NAHIMANA stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 22,090 (▲ € 16,582 vs 2024). filed late Source: NBB ↗
- ATTE GESTION SRL became a director. NBB
- Emmanuel NAHIMANA became a director. NBB
- New establishment in Ans. KBO
- Start of the company according to the CBE. KBO
In short
From € 2,104 loss in 2022 to € 22,090 profit in 2025.
Best year ever: 2025, with € 22,090 profit.
Management
The stake of ATTE GESTION comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE ANS SENTERREThe shares are held by ATTE GESTION (100%).
Directors
According to the 2025 annual accounts
Managing director · represented by Rebecca ATTE
since 2024 · until 2030
Emmanuel NAHIMANA
Director
since 2024 · until 2030
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Walthère Jamar 151
4430 Ans
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0473.720.185
- VAT number
- BE 0473.720.185
- Registered office
- Rue Walthère Jamar 151, 4430 Ans
- Names & denominations
- PHARMACIE ANS SENTERRE · ANS SENTERRE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 January 2001
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers